Detail page

Knowledge Web

Person

Karin Schmidtkunz

Technische Mitarbeiterin

Name	Karin Schmidtkunz
Place	Deutschland
Profession	Technische Mitarbeiterin (characteristic profession)
Related	Albert-Ludwigs-Universität Freiburg. Pharmazeutische und Medizinische Chemie
Further information	Technische Mitarbeiterin Arbeitskreis Manfred Jung, Lehrstuhl Pharmazeutische und Medizinische Chemie
Record type	Person
GND-Identifier	1128189755
Record ID	1128189755
Involved in show all Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement ** Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity First fluorescent acetylspermidine deacetylation assay for HDAC10 identifies selective inhibitors with cellular target engagement Species-selective targeting of pathogens revealed by the atypical structure and active site of Trypanosoma cruzi histone deacetylase DAC2 Sirtuin 1 inhibiting thiocyanates (S1th) - a new class of isotype selective inhibitors of NAD+ dependent lysine deacetylases A novel class of Schistosoma mansoni histone deacetylase 8 (HDAC8) inhibitors identified by structure-based virtual screening and in vitro testing Identification of a small-molecule ligand of the epigenetic reader protein Spindlin1 via a versatile screening platform Metabolic response to XD14 treatment in human breast cancer cell line MCF-7 Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes Selective Sirt2 inhibition by ligand-induced rearrangement of the active site

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Karin Schmidtkunz

Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases

Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells

Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases

Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells

First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement **

Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity

First fluorescent acetylspermidine deacetylation assay for HDAC10 identifies selective inhibitors with cellular target engagement

Species-selective targeting of pathogens revealed by the atypical structure and active site of Trypanosoma cruzi histone deacetylase DAC2

Sirtuin 1 inhibiting thiocyanates (S1th) - a new class of isotype selective inhibitors of NAD+ dependent lysine deacetylases

A novel class of Schistosoma mansoni histone deacetylase 8 (HDAC8) inhibitors identified by structure-based virtual screening and in vitro testing

Identification of a small-molecule ligand of the epigenetic reader protein Spindlin1 via a versatile screening platform

Metabolic response to XD14 treatment in human breast cancer cell line MCF-7

Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes

Selective Sirt2 inhibition by ligand-induced rearrangement of the active site